AirSculpt Technologies shares fell as much as 18.4% to $4.09 in pre-market trading on Monday and were down about 13% by mid-morning after the body-sculpting provider reported weaker second-quarter revenue and cut its full-year profit outlook. Fiscal 2026 second-quarter revenue slipped 3% to $42.9 million, missing the roughly $44.1 million-$44.2 million consensus estimate, while adjusted earnings matched forecasts at $0.01 a share. Net loss widened to $1.1 million from $0.6 million, adjusted EBITDA fell to $4.9 million from $5.8 million, margin narrowed to 11.5% from 13.3%, case volume was nearly flat at 3,376 versus 3,392 a year earlier, and revenue per case declined 2% to $12,707. Management reaffirmed full-year revenue at the lower end of its $151 million-$157 million range but cut adjusted EBITDA guidance to $12 million-$14 million, even as it cited higher marketing spending, an exclusive AlloClae partnership and improved debt and cash levels.